Equities research analysts expect that Ocular Therapeutix, Inc. (NASDAQ:OCUL) will report $14.18 million in sales for the current fiscal quarter, according to Zacks Investment Research. Four analysts have issued estimates for Ocular Therapeutix’s earnings, with the highest sales estimate coming in at $15.30 million and the lowest estimate coming in at $13.47 million. Ocular Therapeutix […]
